VCBeat Health Contact Us
Home ByteDance AI Drug Discovery Spins Off for Independent Funding; Harbour BioMed's B7H4xCD3 Bispecific Antibody IND Application Accepted by NMPA

ByteDance AI Drug Discovery Spins Off for Independent Funding; Harbour BioMed's B7H4xCD3 Bispecific Antibody IND Application Accepted by NMPA

Jun 10, 2026 20:03 CST Updated Jun 11, 02:52
Harbour BioMed

Antibody Drug Developer

DualityBio

Innovative Molecular Type Drug Developer

Laekna Therapeutics

Innovative Drug Developer

Vasque Bio

Developer of Innovative Drugs for Rare Diseases

ApicHope

Innovative Biopharmaceutical R&D Developer